Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Researchers have identified specific genetic markers that predict an individual’s risk of developing adverse side effects from corticosteroid therapy. By integrating pharmacogenomic testing into clinical prescribing protocols, physicians may soon ... Read More
:format(webp)/nginx/o/2026/06/13/17713982t1h6f0a.jpg)
Continuous Coverage
Police in Rio de Janeiro are investigating the assault of a 69-year-old member of the Workers’ Party (PT)…
Chronic liver disease, including cirrhosis, often presents with subtle dermatological markers long before systemic failure occurs. Clinical indicators…
Juventus has listed Jonathan David for sale at 25 million euros, signaling a potential exit after a disappointing…
Dravá Alessi Rose’s electrifying Rock for People performance on June 13, 2026, reignited debates about live music’s role…
LG Electronics has launched its “Partidazos LG” promotional campaign, offering rebates and extended warranties of up to 2,000…
Australia and Turkey face off in a high-stakes World Cup Group D clash on June 13, 2026, with…
Global Affairs
On June 13, 2026, a landscaping entrepreneur in Melbourne proposed an unconventional solution to global demographic decline: incentivizing…
Markets And Money
The U.S. government has mandated that Anthropic, a leading artificial intelligence research company, restrict access to its advanced…
Digital Culture
Why NVIDIA Blackwell Sets New Standards in Agentic AI Infrastructure NVIDIA’s Blackwell platform outperforms competitors by 20x in…
Science And Wellbeing
A global funding crisis and rising political repression have stalled the HIV response, leading to a sharp decline…
Screen And Sound
A Korean home-hack using a drop of rinse on fan blades to combat dust buildup has sparked unexpected…
Fixtures And Form
The National Basketball League (NBL) and Women’s National Basketball League (WNBL) have secured a multi-year commercial partnership with…
